JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (2): 86-89.doi: 10.6040/j.issn.1671-7554.0.2015.748

Previous Articles     Next Articles

Von Hippel-Lindau disease complicated with renal carcinoma: a report of 2 cases

WANG Guangjie, ZU Shulu, ZHANG Xiulin, XU Zhishun, ZHOU Chunwen, LIU Yuqiang, WANG Shaoyong   

  1. Department of Urology, Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Received:2015-08-08 Online:2016-02-10 Published:2016-02-10

Abstract: Objective To explore the clinical characteristics of Von Hippel-Lindau(VHL)disease complicated with renal carcinoma, in order to find better methods of diagnosis and treatment. Methods Clinical data of 2 cases of VHL disease complicated with renal carcinoma were retrospectively analyzed and relevant literature was reviewed. Results One of the 2 patients had family history and underwent right radical nephrectomy. Pathological examination suggested clear-cell carcinoma. No recurrence was found in this patient after one-year follow-up. The other patient did not have family history. He also underwent right radical nephrectomy. Pathological examination suggested multilocular cystic renal cell carcinoma in the right kidney and pheochromocytoma in the right adrenal gland. Four years later, carcinoma was found in the left kidney and left adrenal gland. Pathological examination of biopsy tissue in the left kidney tumor indicated clear-cell carcinoma. He received sorafenib, a molecular targeted drug, and regular hemodialysis. Conclusion VHL disease is a rare cancer syndrome that involves multiple systems. The characteristics of renal cancer concurrent with VHL are different from sporadic one. Early diagnosis and individualized treatment can improve the quality of patients' life. New treatments should be further explored.

Key words: Von Hippel-Lindau disease, Renal tumor, Familial hereditary disease, Clinical characteristics

CLC Number: 

  • R596.1
[1] Hayden MG, Gephart R, Kalanithi P, et al. Von Hippel-Lindau disease in pregnancy: a brief review[J]. J Clin Neurosci, 2009, 16(5): 611-613.
[2] Nordstrom-OBrien M, van der Luijt RB, van Rooijen E, et al. Genetic analysis of von Hippel-Lindau disease[J]. Human mutation, 2010, 31(5): 521-537.
[3] Sharma P, Dhull VS, Bal C, et al. Von Hippel-Lindau syndrome: demonstration of entire disease spectrum with(68)Ga-DOTANOC PET-CT[J]. Korean J Radiol, 2014, 15(1):169-172.
[4] Neumann HP, Bender BU, Berger DP, et al. Prevalence morphology and biology of renal cell carcinoma in Von Hippel-Lindau disease compared to sporadicrenal cell carcinoma[J]. J Urol, 1998, 160(4): 1248-1254.
[5] Duffey BG, Choyke PL, Glenn G, et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease[J]. J Urol, 2004, 172(1): 63-65.
[6] Gupta GN, Peterson J, Thakore KN, et al. Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm[J]. J Urol, 2010, 184(1): 59-63.
[7] Patard JJ. European Association of Urology Guidelines for systemic therapy in metastatic renal cell carcinoma: what is recommended and why?[J]. European Urology Supplements, 2008, 7(2): 46-54.
[8] 赵欣, 徐维锋, 李汉忠. Von Hippel-Lindau病特点分析及外科处理[J]. 癌症进展, 2012, 10(4): 419-423. ZHAO Xin, XU Weifeng, LI Hanzhong. Clinical manifestations and surgical strategies for Von Hippel-Lindau disease[J]. Oncology Progress, 2012, 10(4): 419-423
[9] Jimenez C, Cabanillas ME, Santarpia L, et al. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other Von Hippel-Lindau disease-related tumors[J]. J Clin Endocrinol Metab, 2009, 94(2): 386-391.
[10] Ibáñez de Cáceres I, Cairns P. Methylated DNA sequences for early cancer detection, molecular classification and chemotherapy response prediction[J]. Clin Transl Oncol, 2007, 9(7): 429-437.
[11] Meister M, Choyke P, Anderson C, et al. Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease[J]. Clin Radiol, 2009, 64(6): 589-600.
[12] Roma A, Maruzzo M, Basso U, et al. First-Line sunitinib in patients with renal cell carcinoma(RCC)in von Hippel-Lindau(VHL)disease: clinical outcome and patterns of radiological response[J]. Fam Cancer, 2015, 14(2): 309-316.
[13] Jonasch E, McCutcheon IE, Waguespack SG, et al. Pilot trial of sunitinib therapy in patients with Von Hippel-Lindau disease[J]. Ann Oncol, 2011, 22(12): 2661-2666.
[14] Myong NH, Park BJ. Malignant glioma arising at the site of an excised cerebellar hemangioblastoma after irradiation in a von Hippel-Lindau disease patient[J]. Yonsei Med J, 2009, 50(4): 576-581.
[15] Aiello LP, George DJ, Cahill MT, et al. Rapid and durable recovery of visual function in a patient with Von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416[J]. Ophthalmology, 2002, 109(9): 1745-1751.
[16] Saitta A, Nicolai M, Giovannini A, et al. Juxtapapillary retinal capillary hemangioma: new therapeutic strategies[J]. Med Hypothesis Discov Innov Ophthalmol, 2014, 3(3): 71-75.
[17] Tootee A, Hasani-Ranjbar S. Von Hippel-Lindau disease: a new approach to an old problem[J]. Int J Endocrinol Metab, 2012, 10(4): 619-624.
[1] NIE Siyue, WANG Zhen, SUN Jingyu, LIU Jie, LI Juan, WEI Xiaojuan, LU Chunxiao, L(¨overU)Xingyan, WANG Shuyun, SUN Yuping. Expression and clinical significance of angiopoietin-like protein 5 in human gastric cancer tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 61-65.
[2] REN Juchao, LI Mingbao, LIU Huanyin, FANG Zhiqing, YAN Lei, XU Zhonghua. Clinical value of laparoscopic ultrasonography in assisting laparoscopic partial nephrectomy for centrally located para-hilus renal tumors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 77-80.
[3] YAO Dongxue, ZHAO Qi, QIN Chengyong. Clinical significance of miRNA-206 expression in gastric stromal tumor [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(12): 67-70.
[4] WANG Likui, SANG Hongai, MA Yuyan, XU Yintao, WANG Linlin. Clinical characteristics and pregnancy outcomes of patients with systemic lupus erythematosus: a study of 66 cases with 67 pregnancies [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 69-72.
[5] SUN Chao1,2, XIE Shuang-shuang2, XIAO Di2, LIU Caixia1,2, YU Jin-hong2, LIU Li2, LI Qiang2. Risk factors of acute hepatitis B complicated with
serious hyperbilirubinemia
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(8): 88-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!